Table of Content

Open Access iconOpen Access

RETRACTION

Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]

Chao Jiang*, Xueyan Liu, Meng Wang*, Guoyue Lv*, Guangyi Wang*

* Department of Hepatobiliary Pancreatic Surgery, First Hospital of Jilin University, Changchun, P.R. China
† Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, P.R. China

Oncology Research 2020, 28(7-8), 833-833. https://doi.org/10.3727/096504018X16233193839045

Abstract

This article has no abstract.

Cite This Article

Jiang, C., Liu, X., Wang, M., Lv, G., Wang, G. (2020). Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]. Oncology Research, 28(7-8), 833–833.



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 471

    View

  • 319

    Download

  • 0

    Like

Share Link